CYNK Technology (CYNK) resumed trading Friday, and plenty of shareholders probably wish it hadn’t as they watched CYNK stock plunge nearly 85%.
10 Best Financial Stocks To Own Right Now: MedCAREERS Group Inc (MCGI)
MedCareers Group, Inc., incorporated on December 30, 2004, focus is to develop and build value through its wholly owned subsidiary Nurses Lounge (www.nurseslounge.com), an online professional network and communication source for nurses and organizations connected to the nursing community. On August 10, 2010, MedCareers acquired the workabroad.com Website from Steve Elisberg (Workabroad.com Website).
The Nurses Lounge is a professional network for nursing professionals providing relevant content and information and professional networking. Nurses can subscribe to Lounges created by nursing schools, nurse associations, employers, specialties and more to receive email updates of relevant news, events and other info. Professional networking is a place for nurses to connect with colleagues and network on a professional level.
Advisors' Opinion:- [By Peter Graham]
While small cap green or renewable energy type of stocks have been the flavor of the month for many stock promoters (and sometimes still are), small cap health care stocks like PPJ Enterprise (OTCMKTS: PPJE), Plantation Development Corp (OTCMKTS: BRMA) and MedCAREERS Group Inc (OTCMKTS: MCGI) have also started to get some notice lately ��perhaps because Obamacare has been topping the news lately. However, are these small cap health care stocks a better bet for investors or for their promoters? Here is a quick reality check and a checkup:
- [By Peter Graham]
Last Friday, small cap stocks MedCAREERS Group Inc (OTCMKTS: MCGI), USmart Mobile Device Inc (OTCMKTS: UMDI) and Drinks Americas Holdings, Ltd (OTCMKTS: DKAM) were all over the place with the first two sinking 54% and 48.05%, respectively, while the last one rose 10.81%. It should be mentioned that all three small cap stocks have been the subject of paid promotions albeit none of these stocks have been over promoted. So where can investors and traders expect these stocks to head this week? Here is a quick look at what you might expect:
MedCAREERS Group Inc (OTCMKTS: MCGI) Gets Additional Commitments to Join Its SubsidiarySmall cap MedCAREERS Group aims to develop and build value through its wholly-owned subsidiary Nurses Lounge, Inc., an online professional network and communication source for nurses that offers a 21st century solution to recruitment and information that cannot be accomplished on a static nursing school or association website. On Friday, MedCAREERS Group sank 54% to $0.0575 for a market cap of $3.03 million plus MCGI is up 161.4% since the start of the year and down 93.9% over the past five years according to Google Finance.
Hot Tech Stocks To Watch For 2014: Marketo Inc (MKTO)
Marketo, Inc. (Marketo), incorporated on December 17, 2009, provides cloud-based marketing software platform that enables organizations to engage in modern relationship marketing. The Company�� software platform is designed to enable the execution, management and analytical measurement of marketing activities, helping organizations to acquire new customers. The Company�� platform includes marketing automation, social marketing, sales insight and revenue analytics. Its customer base includes 2,000 customers across a range of industries, including business services, consumer, financial services, healthcare, manufacturing, media, technology and telecommunications. The Company provides its solutions on a subscription basis. Effective December 19, 2013, Marketo Inc acquired Insightera Ltd.
The Company designs, builds and markets a suite of integrated applications to address the needs of modern marketing professionals. The Company�� customers use these applications individually and in combination to streamline and automate marketing processes; develop, retain and extend customer relationships, and measure the positive impact on revenue of marketing programs. Its platform and suite of applications is hosted and delivered over the Web using a cloud-based, or software as a service (SaaS) model, and is built using a multi-tenant architecture. The Company markets and sells its enterprise applications as: Marketo lead management, which includes the core Marketo platform, plus all of the marketing automation capabilities available on the platform; Marketo social marketing, which enables social media campaigns, such as referrals, sweepstakes, and other customer engagement campaigns, and also includes features to add social marketing extensions to traditional marketing campaigns; Marketo sales insight, which provides insights to salespeople about their customers and prospects, and Marketo revenue cycle analytics, which is a suite of analytic tools, analyzers, and ad hoc reporting capabilities taki! ng advantage of its time-series analytics engine.
The Company has built a suite of applications that run on its platform. The applications include marketing automation, social marketing, sales insight and revenue analytics. Marketing automation provides a set of capabilities for marketers to create, automate, and track personalized multi-channel marketing campaigns and relationship-marketing workflows. It includes functionality for marketers to finely segment their prospect and customer database based on collected demographic and behavioral data; generate custom Web pages without programming; send batch and individual personalized marketing messages over email, short message service (SMS) text, and other channels; streamline the entire process of running online (e.g., webinar) and offline (e.g., trade show) marketing events, and to execute multi-step lead nurturing and relationship-marketing campaigns that can run over days, weeks, or months.
Social marketing enables marketers to run social media marketing campaigns, as well as to an increase traditional marketing campaigns with a social marketing aspect in order to amplify marketing messages across social networks. Its solution lets marketers add intelligent social sharing buttons to existing Web content and videos; publish new Facebook pages with the touch of a button; build social engagement applications, such as polls, sweepstakes, and referral offers to engage their audience and promote social cross-posting, and increase existing customer and prospect information with social profiles and sharing behavior.
Sold on a per-seat basis, the Company offers sales insight application to customers utilizing Microsoft dynamics customer relationship management (CRM) or salesforce.com as their CRM system. Revenue Analytics provides a range of ways to help companies understand the correlation between marketing programs and revenue outcomes, and includes: a library of operational reports detailing e-mail and landing page per! formance,! Web activity, and lead performance; intuitive analyzers that show the influence of marketing on individual customer outcomes; analytics that compute and illustrate the impact, effectiveness and return on investment of marketing programs individually and in aggregate, and an ad-hoc report builder for completely customized reports and dashboards.
The Company competes with Act-On, Eloqua, Aprimo, HubSpot, SAS Institute, Unica, ExactTarget, Responsys, Silverpop, Oracle Corporation and SAP AG.
Advisors' Opinion:- [By Lee Jackson]
The Lazard trading desk said that active traders may want to look at software stocks that still had unusually high short interest. Those included Concur Technologies (NASDAQ: CNQR), Tangoe Inc. (NASDAQ: TNGO), Jive Software (NASDAQ: JIVE), Marketo Inc. (NASDAQ: MKTO), VeriSign Inc. (NASDAQ: VRSN) and VMware Inc. (NYSE: VMW). Stocks with high short interest can explode to the upside if the company gets back on track and short sellers are forced to cover.
- [By Jon C. Ogg]
Marketo Inc. (NASDAQ: MKTO) was reinstated as Outperform with a $38 price target (versus a $31.49 close) at Credit Suisse.
Nike Inc. (NYSE: NKE) was started as Neutral at UBS.
- [By Zacks Investment Research]
Marketo (MKTO) is a Zacks Rank #2 (Buy) and has been public since late May. That time horizon has allowed analysts a few chances to increase their estimates.
Hot Tech Stocks To Watch For 2014: Bioanalytical Systems Inc.(BASI)
Bioanalytical Systems, Inc. provides drug discovery and development services for pharmaceutical, biotechnology, academic, and government organizations primarily in North America, the Pacific Rim, and Europe. The company operates in two segments, Contract Research Services and Research Products. The Contract Research Services segment offers various services, including product characterization, method development, and validation; bioanalytical testing to measure drug and metabolite concentrations in complex biological matrices; stability testing to establish and confirm product purity, potency, and shelf life; in vivo sampling services for the continuous monitoring of chemical changes in life; and pharmacokinetic and safety testing services, as well as provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing services. The Research Products segment offers analytical products compris ing liquid chromatographic and electrochemical instruments with associated accessories; in vivo sampling products, such as Culex family of automated in vivo sampling and dosing instruments; and Vetronics? products consisting of instruments and related software to monitor and diagnose cardiac function, and measure other vital physiological parameters in cats and dogs. The company was founded in 1974 and is headquartered in West Lafayette, Indiana.
Advisors' Opinion:- [By Laura Brodbeck]
Monday
Earnings Releases Expected: Steelcase (NYSE: SCS), Bioanalytical Systems (NASDAQ: BASI) Economic Releases Expected: Italian trade balance, Greek current account, US existing home salesTuesday
Hot Tech Stocks To Watch For 2014: KYTHERA Biopharmaceuticals Inc (KYTH)
KYTHERA Biopharmaceuticals, Inc., incorporated in June 2004, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of prescription products for the aesthetic medicine market. The Company�� initial focus is on the facial aesthetics market. The Company�� product candidate, ATX-101, is a injectable drug in Phase III clinical development for the reduction of submental fat, which commonly presents as an undesirable double chin. Based on clinical trials conducted, ATX-101 has exhibited results in the reduction of submental fat. ATX-101 contains a synthetic form of sodium deoxycholate. In the United States and Canada, the Company is conducting two pivotal Phase III trials of ATX-101 for the reduction of submental fat. The Company initiated this pivotal Phase III clinical program, with planned enrollment of 1,000 patients, in March 2012.
In Europe, Bayer, its collaborator outside the United States and Canada, recently completed two pivotal Phase III trials of ATX-101 for the reduction of submental fat. In these multi-center, randomized, double-blind, placebo-controlled pivotal trials involving 723 patients, ATX-101 resulted in a reduction in submental fat, as assessed by a validated clinician scale and a patient satisfaction scale.
ATX-101 contains a synthetic form of sodium deoxycholate. ATX-101 is designed to be a locally-injected drug that causes proximal, preferential destruction of adipocytes, or fat cells, with minimal effect on surrounding tissue. Upon subcutaneous injection under the skin, ATX-101 disrupts cell membranes in protein-poor tissues, such as fat, while being attenuated by interactions with protein-rich tissue, such as skin, muscle and blood vessels. This attenuation by protein-rich tissue results in the preferential destruction of adipocytes by ATX-101. The destruction of adipocytes, or adipocytolysis, elicits a natural response, in which macrophages are attracted to remove cellular debris and fat particles t! hrough the lymphatic system. The macrophages also emit low levels of chemical messengers, known as cytokines, which attract fibroblasts, another cell type, to the area. Fibroblasts produce collagen, and it is believed that new collagen production, or neocollagenesis, promotes retraction of the skin in the areas of fat reduction. The fat removal process with ATX-101 is incremental with each treatment, thereby allowing for control of the aesthetic outcome.
Advisors' Opinion:- [By Lisa Levin]
Kythera Biopharmaceuticals (NASDAQ: KYTH) jumped 24.43% to $41.72 after the company reported positive ATX-101 top line phase III trial results for the reduction of submental fat.
Hot Tech Stocks To Watch For 2014: Hittite Microwave Corporation(HITT)
Hittite Microwave Corporation designs, develops, and sells integrated circuits (ICs), modules, subsystems, and instrumentation products for radio frequency (RF) microwave and millimeterwave applications worldwide. The company?s IC products include amplifiers, digital and voltage variable attenuators, broadband time delays, automatic gain control products, clocks and timing products, comparators, cross point switches, data converters, direct current power conditioning and power management products, dielectric resonator oscillators, frequency dividers and detectors, frequency multipliers, digital logic products, intermediate frequency signal processing products, interface, and limiting amplifiers. Its IC products also comprise mixers and converters, modulators and demodulators, multiplexers/demultiplexers, optical modulator drivers, passives, phase lock loops, phase lock loops with integrated voltage controlled oscillators, phase shifters, power detectors, sensors, switches , Successive detection logarithmic video amplifiers, transimpedance amplifiers, tunable filters, variable gain amplifiers, and voltage controlled and phase locked oscillators. In addition, the company provides signal generators/instrumentation products for engineering, production, and screening applications; connectorized modules for use in test and measurement equipment; RF, microwave, and millimeterwave receivers and synthesizers that are used in military communication, targeting, guidance, and countermeasure systems; and phase locked oscillator modules, which are used in fiber optic test systems. Further, it outsources wafer manufacturing to multiple third party fabricators and foundries. The company sells its products through direct sales force and applications engineering staff, sales representatives, and distributors, as well as through its Web site. Hittite Microwave Corporation was founded in 1985 and is headquartered in Chelmsford, Massachusetts.
Advisors' Opinion:- [By Ant贸nio Costa]
Hittite Microwave Corp (NASDAQ: HITT) is holding up well and looks ready to move higher from here. Next buy point for HITT is at 65.2.
( click to enlarge )Tesla Motors Inc (NASDAQ: TSLA) hits a new 52 week high and held up very well when the nasdaq was tanking. The stock is on fire.
- [By Harsh Chauhan]
It is not just auto companies that are benefiting from this growth. Even chipmakers have cashed in on this trend as vehicles get more advanced and are equipped with more technology. Analog Devices (NASDAQ: ADI ) is one such semiconductor company which has trained its sights on the resurgent auto market. It recently announced the acquisition of Hittite Microwave (NASDAQ: HITT ) to bolster its position in automotive, along with other verticals.�
- [By Ben Levisohn]
Walt Disney rose 1% to $85.48, making it the biggest percentage gainer in the Dow Industrial Averages. International Game Technology jumped 14% to $55.31 today, putting it atop the S&P 500. Reuters reported that International Game Technology has hired Morgan Stanley to help sell the company.
Analog Devices advanced 5% to $55.31 today, making it the big winner in the Nasdaq 100. Analog Devices agreed to buy chip-maker Hittite Microwave (HITT) for $78 a share. Hittite soared 29% to $77.90 today.Idenix Pharmaceuticals more than tripled today after Merck (MRK) agreed to purchase the biotech company for nearly $4 billion. Idenix surged 229% to $23.79 today, while Merck ticked up 0.2% to $57.94.
No comments:
Post a Comment